Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
State Street SPDR S&P Homebuilders ETFTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs State Street SPDR S&P Homebuilders ETF — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.03B), while State Street SPDR S&P Homebuilders ETF trades at $92.84 (market cap $1.53B). The key difference: Indivior Pharmaceuticals Inc. Common Stock is far larger — about 2.6× State Street SPDR S&P Homebuilders ETF's market cap, and Indivior Pharmaceuticals Inc. Common Stock is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and State Street SPDR S&P Homebuilders ETF for 35 Days on average.

INDVXHB
Market Cap
$4.03B$1.53B
Volume
2,781,1711,987,449
Sector
HealthBroad Market / Factor
52-Week High
$41.83$121.36
52-Week Low
$24.09$92.84
Typical Hold Time
0 Days35 Days
Enterprise Value
$4.32B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

State Street SPDR S&P Homebuilders ETF

XHB (SPDR S&P Homebuilders ETF) trades at $94.70, up 0.69% on the day, but faces strong technical headwinds with a bearish moving average signal and key resistance at $95. The ETF reflects the homebuilding sector's sensitivity to mortgage rates, which recently hit 7%, pressuring valuations despite some positive housing data. Recent institutional activity shows mixed sentiment, with Greenland Capital adding a $17.33 million position while CoreCap Advisors reduced its stake by 99.3% in Q2 2026.

The outlook remains cautious amid high mortgage rates and mixed housing data, though potential catalysts include new housing legislation and undervalued sector signals. Risks include rate sensitivity and economic volatility, but long-term exposure to housing demand offers rebound potential. Wall Street sentiment is neutral with focus on affordability trends and policy impacts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
XHB

No sentiment data available yet.

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About State Street SPDR S&P Homebuilders ETF

XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.

Read more on XHB →